What is Acadia Pharmaceuticals's revenue?

Acadia Pharmaceuticals (ACAD) generated $1.1B in revenue over the trailing twelve months, up 9.9% year over year.

Is Acadia Pharmaceuticals profitable?

Acadia Pharmaceuticals reported $375.7M in net income over the trailing twelve months, a 34.3% net margin.

What are Acadia Pharmaceuticals's profit margins?

Gross margin is 91.5% and operating margin is 7.4%, with a 34.3% net margin.

What is Acadia Pharmaceuticals's earnings per share?

Acadia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.21.

Where does Acadia Pharmaceuticals's income statement data come from?

Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Acadia Pharmaceuticals ACAD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$268.06M+9.7%	$283.99M+9.4%	$278.63M+11.3%	$264.57M+9.3%	$244.32M+18.7%
Total cost of revenue	$24.79M+21.6%	$26.23M+20.3%	$21.65M+14.8%	$20.73M+13.7%	$20.39M-11.1%
Gross profit	$243.27M+8.6%	$257.76M+8.4%	$256.99M+11.0%	$243.83M+9.0%	$223.93M+22.4%
Gross margin	90.8%-0.9pp	90.8%-0.8pp	92.2%-0.2pp	92.2%-0.3pp	91.7%+2.8pp
Research and development	$76.87M-1.8%	$84.76M-15.9%	$87.83M+31.9%	$77.95M+2.3%	$78.27M+31.1%
Selling, general and administrative	$171.02M+35.3%	$155.62M+19.6%	$133.4M+0.1%	$133.51M+14.0%	$126.37M+17.0%
Total costs & expenses	$272.68M+21.2%	$266.6M+151%	$242.88M+11.0%	$232.19M+9.8%	$225.03M+18.0%
Operating income	-$4.62M-124%	$17.39M-88.7%	$35.76M+13.0%	$32.37M+6.4%	$19.29M+26.8%
Operating margin	-1.7%-9.6pp	6.1%-53.0pp	12.8%+0.2pp	12.2%-0.3pp	7.9%+0.5pp
Interest expense	$8.06M+1.9%	$8.33M+18.9%	$8.25M+25.2%	$7.24M+13.9%	$7.9M+43.5%
Other income (expense), net	$542K-7.8%	$596K+3.7%	$593K+3.0%	$594K+53.9%	$588K+106%
Income before income taxes	$3.98M-85.7%	$26.32M-83.7%	$44.6M+14.9%	$40.21M+8.1%	$27.78M+32.3%
Income tax expense	$344K-96.1%	-$247.25M-1,526%	-$27.18M-550%	$13.55M+257%	$8.79M+97.7%
Net income	$3.64M-80.8%	$273.57M+90.3%	$71.78M+119%	$26.67M-20.1%	$18.99M+14.7%
Net margin	1.4%-6.4pp	96.3%+41.0pp	25.8%+12.7pp	10.1%-3.7pp	7.8%-0.3pp
Diluted earnings per share	$0.02-81.8%	$1.61+87.2%	$0.42+110%	$0.16-20.0%	$0.11+10.0%
EBITDA	-$1.62M-107%	$20.32M-87.2%	$38.71M+13.1%	$35.31M+7.0%	$22.24M+7.2%
EBITDA margin	-0.6%-9.7pp	7.2%-54.0pp	13.9%+0.2pp	13.3%-0.3pp	9.1%-1.0pp
EBIT	-$4.62M-124%	$17.39M-88.7%	$35.76M+13.0%	$32.37M+6.4%	$19.29M+26.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Acadia Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's revenue?: Acadia Pharmaceuticals (ACAD) generated $1.1B in revenue over the trailing twelve months, up 9.9% year over year.
Is Acadia Pharmaceuticals profitable?: Acadia Pharmaceuticals reported $375.7M in net income over the trailing twelve months, a 34.3% net margin.
What are Acadia Pharmaceuticals's profit margins?: Gross margin is 91.5% and operating margin is 7.4%, with a 34.3% net margin.
What is Acadia Pharmaceuticals's earnings per share?: Acadia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.21.
Where does Acadia Pharmaceuticals's income statement data come from?: Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.